SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,785.00    90.00 (1.34%)
Bid:
6,785.00
Ask:
6,795.00
Spread: 10.00 (0.147%)
Market Cap: £5.01b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Vulcanic Acquisition Agreement Executed

25 Jul 2022 07:30

RNS Number : 5266T
Spirax-Sarco Engineering PLC
25 July 2022
 

 

News Release

 

25th July 2022

 

Acquisition of Vulcanic - Definitive Agreement Executed

Spirax-Sarco Engineering plc, the thermal energy management and niche pumping specialist, announces that it has now signed a binding definitive agreement to acquire the Vulcanic Group of Companies (Vulcanic) from Qualium, a French private equity company, for a consideration of €261.7 million on a cash and debt free basis, subject to customary closing adjustments.

 

Signature of this definitive agreement follows the conclusion of exclusive negotiations announced on 4th July 2022.

 

As previously stated, the transaction will require regulatory approvals in France and Germany. These regulatory approvals and completion are expected during the third quarter of the year.

 

 

 

Enquiries:

Nimesh Patel, Chief Financial Officer

Andrew Guthrie, Head of Investor Relations

Tel: +44 01242 535035

 

 

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading Businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions Businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both Businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs more than 8,700 people, including almost 2,000 direct sales and service engineers. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

 

Further information can be found at www.spiraxsarcoengineering.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQGZGZNLDZGZZM
Date   Source Headline
20th Nov 20085:11 pmRNSTransaction in Own Shares
19th Nov 20085:28 pmRNSTransaction in Own Shares
18th Nov 20085:27 pmRNSTransaction in Own Shares
17th Nov 20085:16 pmRNSTransaction in Own Shares
14th Nov 20085:07 pmRNSTransaction in Own Shares
13th Nov 20085:26 pmRNSTransaction in Own Shares
12th Nov 20085:10 pmRNSTransaction in Own Shares
11th Nov 20085:19 pmRNSTransaction in Own Shares
10th Nov 20085:17 pmRNSTransaction in Own Shares
10th Nov 20082:12 pmRNSDirector/PDMR Shareholding
7th Nov 20087:00 amRNSInterim Management Statement
5th Nov 20085:22 pmRNSHolding(s) in Company
4th Nov 20089:56 amRNSAcquisition
3rd Nov 20082:54 pmRNSTotal Voting Rights
7th Oct 20089:24 amRNSDirector/PDMR Shareholding
1st Oct 20089:38 amRNSTotal Voting Rights
30th Sep 200810:52 amRNSDirector/PDMR Shareholding
1st Sep 20082:36 pmRNSTotal Voting Rights
27th Aug 20087:00 amRNS2008 Half Year Results
11th Aug 200812:36 pmRNSNotice of Results
8th Aug 20083:15 pmRNSHolding(s) in Company
1st Aug 20083:55 pmRNSTotal Voting Rights
2nd Jul 20082:10 pmRNSTotal Voting Rights
18th Jun 200811:55 amRNSHolding(s) in Company
16th Jun 200812:21 pmRNSHolding(s) in Company
9th Jun 20084:45 pmRNSHolding(s) in Company
4th Jun 20082:33 pmRNSNotification of Major Interes
2nd Jun 20089:00 amRNSTotal Voting Rights
21st May 20084:12 pmRNSDirector/PDMR Shareholding
15th May 20083:54 pmRNSHolding(s) in Company
15th May 20083:37 pmRNSHolding(s) in Company
13th May 200812:00 pmRNSInterim Management Statement
13th May 200812:00 pmRNSInterim Management Statement
1st May 200810:03 amRNSTotal Voting Rights
1st Apr 200810:32 amRNSTotal Voting Rights
12th Mar 20084:55 pmRNSDirector/PDMR Shareholding
11th Mar 200812:11 pmRNSDirector/PDMR Shareholding
10th Mar 20087:01 amRNSFinal Results
3rd Mar 20089:09 amRNSTotal Voting Rights
3rd Mar 20088:54 amRNSAcquisition
27th Feb 20083:49 pmRNSNotice of Results
1st Feb 20081:41 pmRNSTotal Voting Rights
1st Feb 20081:39 pmRNSAcquisition
4th Jan 20089:57 amRNSTotal Voting Rights
20th Dec 20075:02 pmRNSDirector/PDMR Shareholding
20th Dec 20074:58 pmRNSDirector/PDMR Shareholding
13th Dec 200710:23 amRNSBoard Changes
3rd Dec 200711:39 amRNSTotal Voting Rights
16th Nov 20075:41 pmRNSHolding(s) in Company
12th Nov 20073:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.